Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Valproic Acid at Therapeutic Plasma Levels May Increase 5-Azacytidine Efficacy in Higher Risk Myelodysplastic Syndromes
Clinical Cancer Research, 08/04/09
Voso MT et al. – The data show that the 5–AZA/VPA combination is active and safe in patients with MDS with a poor prognosis. Achievement of VPA therapeutic levels may indeed increase 5–AZA efficacy.
Related Articles
Hematopoiesis-related microRNA expression in myelodysplastic syndromes
Leukemia and Lymphoma, 11/06/09
Relevance Score: 67%%
Cytogenetic features and prognosis analysis in Chinese patients with myelodysplastic syndrome: a multicenter study
Annals of Hematology, 11/25/09
Relevance Score: 66%%
School of Pharmacy Hopes to Close Clinical Gap for Elderly Blood Disorder
Internet Source, 11/05/09
Relevance Score: 65%%
A Case of Myelodysplastic Syndrome in a Liver Transplant Patient
Transplantation Proceedings, 11/17/09
Relevance Score: 64%%
Prognostic impact of pre-transplantation transfusion history and secondary iron overload in patients with myelodysplastic syndrome undergoing allogeneic stem cell transplantation: a study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO)
Haematologica, 11/16/09
Relevance Score: 64%%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Multi-step binding of ADAMTS-13 to von Willebrand factor
Journal of Thrombosis and Haemostasis, 12/02/09
Combined genetic effect of CDK7 and ESR1 polymorphisms on breast cancer
Breast Cancer Research and Treatment, 12/02/09
UHRF1 is associated with epigenetic silencing of BRCA1 in sporadic breast cancer
Breast Cancer Research and Treatment, 12/02/09
Today in Myeloproliferative Dz...keeping you current
Receive free subspecialty "5-minute updates" via email
Environmental-mediated drug resistance: a target for multiple myeloma therapy
Expert Review of Hematology, 12/02/09
Clinical significance of V617F mutation of the JAK2 gene in patients with chronic myeloproliferative disorders
Hematology, 12/02/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


